PAI
Palo Alto Investors Portfolio holdings
AUM
$470M
1-Year Return
2.57%
This Quarter Return
-22.73%
1 Year Return
+2.57%
3 Year Return
+93.77%
5 Year Return
+190.64%
10 Year Return
+955.02%
AUM
$1.29B
AUM Growth
-$508M
(-28%)
Cap. Flow
-$34M
Cap. Flow
% of AUM
-2.64%
Top 10 Holdings %
Top 10 Hldgs %
71.19%
Holding
44
New
1
Increased
10
Reduced
7
Closed
–
Top Buys
| 1 |
Acadia Pharmaceuticals
ACAD
|
+$13.6M |
| 2 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
+$1.7M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
+$1.65M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$976K |
| 5 |
United Therapeutics
UTHR
|
+$780K |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$53.4M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
+$1.66M |
| 3 |
STAAR Surgical
STAA
|
+$184K |
| 4 |
Karyopharm Therapeutics
KPTI
|
+$129K |
| 5 |
EPZM
Epizyme, Inc
EPZM
|
+$66.7K |
Sector Composition
| 1 | Healthcare | 81.45% |
